| 000 | 01163 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516005651.0 | ||
| 264 | 0 | _c20110114 | |
| 008 | 201101s 0 0 eng d | ||
| 022 | _a1879-3185 | ||
| 024 | 7 |
_a10.1016/j.tox.2010.10.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAmacher, David E | |
| 245 | 0 | 0 |
_aStrategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studies. _h[electronic resource] |
| 260 |
_bToxicology _cJan 2011 |
||
| 300 |
_a10-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xdiagnosis |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 |
_aFatty Liver _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitochondria _xmetabolism |
| 650 | 0 | 4 |
_aToxicity Tests _xmethods |
| 773 | 0 |
_tToxicology _gvol. 279 _gno. 1-3 _gp. 10-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tox.2010.10.006 _zAvailable from publisher's website |
| 999 |
_c20275192 _d20275192 |
||